Universal BRCA testing worthwhile for relatives of high-grade serous ovarian cancer patientsApril 28, 2018Gynecologic CancerBreast CancerPreventive Care
Early breast cancer: Patients report favorable quality of life after partial breast irradiationApril 25, 2018Breast CancerPatient & Survivor Care
Hormone therapy raises diabetes risk in breast cancer survivorsApril 24, 2018Breast CancerPatient & Survivor Care
OlympiAD: No statistically significant boost in OS with olaparib in HER2-negative mBCApril 16, 2018Breast Cancer
Sarcopenia, body fat linked with mortality in nonmetastatic breast cancerApril 4, 2018Breast CancerPatient & Survivor Care
21-gene assay predicts survival in male and female breast cancerApril 3, 2018Breast CancerPatient & Survivor Care
Think about breast cancer surveillance for transgender patientsMarch 30, 2018Rare DiseasesBreast Cancer
Over one-third report financial burden from breast cancer treatmentMarch 27, 2018Breast CancerPatient & Survivor Care
HDAC inhibition may boost immune therapy efficacy in breast cancerMarch 27, 2018Immuno-oncologyBreast Cancer
Late toxicities with PARP inhibitor plus RT in inflammatory breast cancerMarch 23, 2018Breast CancerPatient & Survivor Care
Fulvestrant plus neratinib reversed treatment-acquired HER2 mutations in metastatic ER+ breast cancerMarch 19, 2018Breast Cancer
Gaps exist in receipt of clinically indicated genetic counseling after breast cancer diagnosisMarch 12, 2018Breast CancerPatient & Survivor Care
